From May 9, 2024 to June 30, 2024, the company has repurchased 7,117,700 shares, representing 1.96% for ¥11,361.01 million. With this, the company has completed the repurchase of 7,117,700 shares, representing 1.96% for ¥11,361.01 million under the buyback announced on May 9, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,681 JPY | +0.99% |
|
+3.32% | +19.64% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.64% | 3.67B | |
+54.07% | 816B | |
+38.59% | 634B | |
-7.05% | 351B | |
+15.44% | 323B | |
+5.72% | 293B | |
+13.40% | 238B | |
+0.61% | 222B | |
+13.24% | 218B | |
+7.42% | 167B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 9, 2024.